The global iron-deficiency anemia therapy market is experiencing significant growth, driven by the rising incidences of iron deficiency anemia, introduction of novel drugs in the market, and inclination towards social healthcare on women health specifically anemia. The market is characterized by the presence of a large number of players offering a wide range of therapies tailored to meet the diverse needs of healthcare providers in the region.
